EVOFEM BIOSCIENCES, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
EVOFEM BIOSCIENCES, INC. (EVFM) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $393.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-11
- EVOFEM BIOSCIENCES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $393.00K.
- EVOFEM BIOSCIENCES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$8.86M, a 116.72% decline from fiscal 2023.
- EVOFEM BIOSCIENCES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $53.00M.
- EVOFEM BIOSCIENCES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$76.65M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | $393.00K 10-K · filed 2026-03-11 |
| 2024-12-31 | -$8.86M 10-K · filed 2026-03-11 |
| 2023-12-31 | $53.00M 10-K · filed 2025-03-24 |
| 2022-12-31 | -$76.65M 10-K · filed 2024-03-27 |
| 2021-12-31 | -$205.18M 10-K · filed 2023-04-27 |
| 2020-12-31 | -$142.31M 10-K · filed 2022-03-10 |
| 2019-12-31 | -$80.03M 10-K · filed 2021-03-04 |
| 2018-12-31 | -$125.67M 10-K · filed 2020-03-12 |
| 2017-12-31 | -$105.22M 10-K · filed 2019-03-01 |
| 2016-12-31 | -$65.86M 8-K/A · filed 2018-04-06 |